“…But as Figure 1 shows, many states had low-dosage policies in place after this (and, as a result, look more like 1.0 policies), and some states moved from low- to high-dosage policies in recent years, so timing of adoption is a rough indicator of the strength of a particular policy. Other studies define PBF 1.0 and 2.0 by states linking bonus versus base funding to performance, respectively (e.g., Favero & Rutherford, 2020; Gándara & Rutherford, 2020; Serna, 2020). However, Figure 1 shows that many states have low-dosage policies, regardless of whether bonus or base funds are linked to performance.…”